X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Freedom, at a 'Price' - Views on News from Equitymaster
 
 
  • PRINT
  • E-MAIL
  • FEEDBACK
  • A  A  A
  • Mar 26, 2007

    Freedom, at a 'Price'

    And we thought Dr. Singh with the help of Mr. Rao, had effectively negated much of the dreaded 'License Raj' in his earlier tryst with governance in the early nineties. Last week Friday, quite a few newspapers carried a picture of three very tense-looking Cement Manufacturers Association (CMA) office-bearers discussing strategy outside the hallowed portals of North Block, the seat of India's Ministry of Finance.

    With all this hoop-la about cement prices, one is pardoned if he believed cement prices to be the major culprit behind the current upsurge in the inflation rate as measured by the Wholesale Price Index (WPI). The truth is cement has a weight of 1.7% and has contributed just 4.5% of the total 4.9% increase in the WPI. Fruits and wheat have almost the same weight and similar shares in the total inflation, but we have yet to hear any pro-active measures undertaken by this government on their supply and pricing.

    Dr. Singh's government is also going back on the earlier Congress government's initiative on the Drug Price Control Order (DPCO). Introduced in 1970, this draconian law brought pricing of 97% of drugs sold in India under price control of the central government. In 1995, the Rao government pared it down to 75 drugs accounting to 40% of the market. In FY02, they were to prune this list to 25 essential drugs. Instead we find Dr. Singh, alongwith his crew of ministers, is planning to extend the DPCO again to affect almost 80% of the medicines.

    Will affordability increase the usage? The problem in India is less of affordability and more of accessibility. The government health care agencies are barely stocked with essential medicines, sometimes are non-existent. If this government is intent on going back on its earlier resolve, it raises serious doubts about the credibility of the reform process itself, driving out future investments.

    Also the moral thread running through the price-fixing attitude of the government provides some food for thought. With more than 41% of the population now below the age of 25 years, a majority of Indians today have not been through the most repressive decade of India's economic history, the fruits of whose labour we still find fettering us. Apart from bank nationalisation, some of the most ghastly economic laws - the MRTP Act, Small Scale Reservation Act, FERA, Amended Industrial Disputes Act to finally apply it to many more units, Urban Land Ceiling Act, DPCO, quantitative and tariff curbs on imports - all happened during this period.

    Besides preferential policies many times more comprehensive and detailed than similar US affirmative action programs, social policies have included labour market and employment policies, government control over the broadcast media, and socialistic educational and housing programs. These have gone hand-in-hand with the unrestrained growth of a bureaucratic, re-distributive state.

    A point to ponder about is that after the partial steps taken in the early 1990s towards a pre-1969 India, by dismantling most of Ms. Gandhi's economic legacy, the levels of competition have dramatically improved. By paring the role of its government, India is steps closer to a meritocratic society. Today, a person from India's remote corners can trade on the stock exchanges, access the Internet, talk over his cell phone if not the landline! We can see the burgeoning of growth from the staid 'Hindu' rate of 3.5% (enough for sustaining the increased population) to a new trend of 7% plus. As a result, the secessionist demands of various fragmented groups have reduced. India is looking much stronger than it ever did since 1967.

    We cannot afford to go up the 'socialist' path again. All these 'pricing' theories are best left to the markets.

     

     

    Equitymaster requests your view! Post a comment on "Freedom, at a 'Price'". Click here!

      
     

    More Views on News

    How to Ride Alongside India's Best Fund Managers (The 5 Minute Wrapup)

    Jun 10, 2017

    Forty Indian investing gurus, as worthy of imitation as the legendary Peter Lynch, can help you get rich in the stock market.

    Why NOW Is the WORST Time for Index Investing (The 5 Minute Wrapup)

    Aug 18, 2017

    Buying the index now will hardly help make money in stocks even in ten years.

    Trump Takes a Beating (Vivek Kaul's Diary)

    Aug 18, 2017

    Donald J Trump, a wrasslin' fan, took a 'Holy Sh*t!' blow on Tuesday.

    How To Read Your Mutual Fund Account Statement Correctly (Outside View)

    Aug 17, 2017

    PersonalFN simplifies the mutual fund account statement for you.

    This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process) (The 5 Minute Wrapup)

    Aug 17, 2017

    A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

    More Views on News

    Most Popular

    Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

    Aug 7, 2017

    The data tells us quite a different story from the one the government is trying to project.

    A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

    Aug 10, 2017

    Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

    Aug 7, 2017

    Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

    More
    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
     

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms

    S&P BSE SENSEX


    Aug 18, 2017 02:29 PM

    MARKET STATS